Facebook
Twitter
Telegram
Report an ErrorLexicon Pharmaceuticals Cash Flow 2011-2024 | LXRX
Annual Cash Flow Lexicon Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-162 M | -88.9 M | -87 M | -143 M | 114 M | -149 M | -185 M | -176 M | 185 M | -75.6 M | -91.1 M | -94.5 M | -87.9 M |
Depreciation & Amortization |
554 K | 427 K | 292 K | 2.93 M | 3.65 M | 3.68 M | 3.4 M | 2.06 M | 727 K | 1.93 M | 2.86 M | 4.19 M | 4.89 M |
Accounts Payables |
14.4 M | 10.4 M | 9.15 M | 5.47 M | 12.2 M | 17.8 M | 57.7 M | 52.9 M | 19.7 M | 13.1 M | 9.72 M | 7.66 M | 6.04 M |
Accounts Receivables |
1.01 M | 28 K | 14 K | 395 K | 56.5 M | 5.92 M | 4.82 M | 7.49 M | 911 K | 1.04 M | 790 K | 1.38 M | 350 K |
Total Inventories |
381 K | - | - | - | 4.24 M | 4.68 M | 1.95 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Lexicon Pharmaceuticals
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-55.1 M | - | - | -31.6 M | - | -67.3 M | - | -23.4 M | - | -64.2 M | - | -25.2 M | - | -109 M | -68.4 M | -22.1 M | - | 138 M | - | -52.5 M | - | -121 M | -99.3 M | -46.8 M | - | -152 M | -118 M | -85.5 M | - | -127 M | -91.6 M | -43.7 M | - | -81.1 M | -55.7 M | -23.5 M | - | -71.2 M | -50 M | -30.3 M | - | -69.3 M | -45.4 M | -24.3 M | - | -74 M | -49 M | -27 M | - | -65.4 M | -45.2 M | -21.5 M |
Depreciation & Amortization |
144 K | - | - | 112 K | - | 324 K | - | 109 K | - | 180 K | - | 37 K | - | 2.59 M | 1.81 M | 906 K | - | 2.72 M | - | 1.81 M | - | 2.77 M | 1.85 M | 925 K | - | 2.48 M | 1.55 M | 634 K | - | 1.55 M | 1.04 M | 521 K | - | 661 K | 601 K | 355 K | - | 1.72 M | 1.2 M | 644 K | - | 2.19 M | 1.62 M | 793 K | - | 3.27 M | 2.22 M | 1.12 M | - | 3.75 M | 2.57 M | 1.31 M |
Accounts Payables |
8.07 M | 12 M | 10.5 M | 10.3 M | 10.4 M | 9.43 M | - | 9.32 M | 9.15 M | 8.34 M | 8.54 M | 4.93 M | 5.47 M | 5.47 M | 5.47 M | 5.47 M | 12.2 M | 12.2 M | 10 M | 12.2 M | 12.1 M | 17.8 M | 17.8 M | 17.8 M | 38.8 M | 57.7 M | 57.7 M | 57.7 M | 52.9 M | 52.9 M | 52.9 M | 52.9 M | 19.7 M | 19.7 M | 19.7 M | 19.7 M | 13.1 M | 13.1 M | 13.1 M | 13.1 M | 9.72 M | 9.72 M | 9.72 M | 9.72 M | 7.66 M | 7.66 M | 7.66 M | 7.66 M | 6.04 M | 6.04 M | 6.04 M | 6.04 M |
Accounts Receivables |
1.53 M | 318 K | 685 K | 261 K | 28 K | 39 K | - | 37 K | 14 K | 23 K | 159 K | 101 K | 395 K | 395 K | 395 K | 395 K | 56.5 M | 56.5 M | 5.58 M | 56.5 M | 5.92 M | 5.92 M | 5.92 M | 5.92 M | 4.82 M | 4.82 M | 4.82 M | 4.82 M | 7.49 M | 7.49 M | 7.49 M | 7.49 M | 911 K | 911 K | 911 K | 911 K | 1.04 M | 1.04 M | 1.04 M | 1.04 M | 790 K | 790 K | 790 K | 790 K | 1.38 M | 1.38 M | 1.38 M | 1.38 M | 350 K | 350 K | 350 K | 350 K |
Total Inventories |
514 K | 336 K | 172 K | - | - | - | - | - | - | - | - | - | - | - | 3.99 M | 4.15 M | 4.24 M | 4.24 M | 4.28 M | 4.24 M | 4.68 M | 4.68 M | 4.68 M | 4.68 M | 1.95 M | 1.95 M | 1.95 M | 1.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency